Just released from FDAnews — Investigations Operations Manual 2014 — the FDA’s own internal guidance on how to inspect a drug or device company. Know what the investigators look for — before they even get there.

GenPath Pharmaceuticals Becomes AVEO Pharmaceuticals

GenPath Pharmaceuticals, a drug discovery and development company focused on
the treatment of cancer and other diseases, announced that it has changed its
corporate name to AVEO Pharmaceuticals. "The name change, together with
the recent relocation to our new and expanded facility, marks the next phase
of growth for our company," said Tuan Ha-Ngoc, president and CEO of AVEO
Pharmaceuticals.